Correction: Regulation of minichromosome maintenance gene family by MicroRNA-1296 and genistein in prostate cancer (Cancer Research (2010)70 (2809-2818) DOI: 10.1158/0008-5472.CAN-09-4176);Regulation of minichromosome maintenance gene family by MicroRNA-1296 and genistein in prostate cancer

Cancer Research

Volumn 70, Issue 7, 2010, Pages 2809-2818

  Majid, Shahana ^a   Dar, Altaf A ^b   Saini, Sharanjot ^a   Chen, Yi ^a   Shahryari, Varahram ^a   Liu, Jan ^a   Zaman, Mohd Saif ^a   Hirata, Hiroshi ^a   Yamamura, Soichiro ^a   Ueno, Koji ^a   Tanaka, Yuichiro ^a   Dahiya, Rajvir ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; GENISTEIN; MESSENGER RNA; MICRORNA; MICRORNA 1296; MINICHROMOSOME MAINTENANCE PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 7; REPLICATION LICENSING FACTOR CDT1; SMALL INTERFERING RNA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE S PHASE; CHROMATIN; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RNA INTERFERENCE; UPREGULATION;

EID: 77950822746     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-18-1117     Document Type: Erratum

References (44)

1. Kearsey SE, Labib K. MCM proteins: evolution, properties, and role in DNA replication. Biochim Biophys Acta 1998; 1398: 113-136 (Pubitemid 28305206)
2. Maiorano D, Lutzmann M, Mechali M. MCM proteins and DNA replication. Curr Opin Cell Biol 2006; 18: 130-136
3. Alison MR, Hurt T, Forbes SJ. Minichromosome maintenance (MCM) proteins may be pre-cancer markers. Gut 2002; 50: 290-291
4. Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 1999; 5: 2121-2132 (Pubitemid 29399268)
5. Rowles A, Chong JP, Brown L, Howell M, Evan Gl, Blow JJ. Interaction between the origin recognition complex and the replication licensing system in Xenopus. Cell 1996; 87: 287-296 (Pubitemid 26359006)
6. Maiorano D, Moreau J, Mechali M. XCDT1 is required for the assembly of pre-replicative complexes in Xenopus laevis. Nature 2000; 404: 622-625 (Pubitemid 30205062)
7. Zegerman P, Diffley JF. Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast. Nature 2007; 445: 281-285 (Pubitemid 46122811)
8. Sheu YJ, Stillman B. Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression. Mol Cell 2006; 24: 101-113 (Pubitemid 44466677)
9. Madine MA, Khoo CY, Mills AD, Laskey RA. MCM3 complex required for cell cycle regulation of DNA replication in vertebrate cells. Nature 1995; 375: 421-424
10. Labib K, Tercero JA, Diffley JF. Uninterrupted MCM2-7 function re-quired for DNA replication fork progression. Science 2000; 288: 1643-1647 (Pubitemid 30387430)
11. Chong JP, Mahbubani HM, Khoo CY, Blow JJ. Purification of an MCM-containing complex as a component of the DNA replication licensing system. Nature 1995; 375: 418-421
12. Schwacha A, Bell SP. Interactions between two catalytically distinct MCM subgroups are essential for coordinated ATP hydrolysis and DNA replication. Mol Cell 2001; 8: 1093-1104 (Pubitemid 34031811)
13. Davey MJ, Indiani C, O'Donnell M. Reconstitution of the Mcm2-7p heterohexamer, subunit arrangement, and ATP site architecture. J Biol Chem 2003; 278: 4491-4499 (Pubitemid 36800944)
14. Ying CY, Gautier J. The ATPase activity of MCM2-7 is dispensable for pre-RC assembly but is required for DNA unwinding. EMBO J 2005; 24: 4334-4344 (Pubitemid 41828908)
15. Davis RL, Onda K, Shubuya M, Lambom K, Hoshino T. Proliferation markers in gliomas: a comparison of BUDR, KI-67, and MIB-1. J Neurooncol 1995; 24: 9-12.
16. Blow JJ, Hodgson B. Replication licensing-defining the proliferative state? Trends Cell Biol 2002; 12: 72-78
17. Holthoff HP, Baack M, Richter A, Ritzi M, Knippers R. Human protein MCM6 on HeLa cell chromatin. J Biol Chem 1998; 273: 7320-7325 (Pubitemid 28152750)
18. Musahl C, Holthoff HP, Lesch R, Knippers R. Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. Exp Cell Res 1998; 241: 260-264 (Pubitemid 28366601)
19. Thommes P, Fett R, Schray B, et al. Properties of the nuclear P1 protein, a mammalian homologue of the yeast Mcm3 replication protein. Nucleic Acids Res 1992; 20: 1069-1074
20. Krude T, Musahl C, Laskey RA, Knippers R. Human replication proteins hCdc21, hCdc46 and P1Mcm3 bind chromatin uniformly before S-phase and are displaced locally during DNA replication. J Cell Sci 1996; 109 (Pt 2): 309-318 (Pubitemid 26057113)
21. 1 that controls entry into the cell cycle. Mol Cell Biol 2003; 23: 2351-2361
22. Obermann EC, Eward KL, Dogan A, et al. DNA replication licensing in peripheral B-cell lymphoma. J Pathol 2005; 205: 318-328 (Pubitemid 40253922)
23. Going JJ, Keith WN, Neilson L, Stoeber K, Stuart RC, Williams GH. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. Gut 2002; 50: 373-377 (Pubitemid 34161054)
24. Hunt DP, Freeman A, Morris LS, et al. Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenances protein. Br J Neurosurg 2002; 16: 10-15 (Pubitemid 34246180)
25. Chatrath P, Scott IS, Morris LS, et al. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer 2003; 89: 1048-1054 (Pubitemid 37239210)
26. Ramnath N, Hemandez FJ, Tan DF, et al. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol 2001; 19: 4259-4266 (Pubitemid 33081644)
27. Tan DF, Huberman JA, Hyland A, et al. MCM2-a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer 2001; 1: 6.
28. Gonzalez MA, Pinder SE, Callagy G, et al. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol 2003; 21: 4306-4313 (Pubitemid 46628462)
29. Hiraiwa A, Fujita M, Nagasaka T, Adachi A, Ohashi M, lshibashi M. Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth. Int J Cancer 1997; 74: 180-184 (Pubitemid 27234507)
30. Padmanabhan V, Callas P, Philips G, Trainer TD, Beatty BG. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J Clin Pathol 2004; 57: 1057-1062 (Pubitemid 39331356)
31. Rodins K, Cheale M, Coleman N, Fox SB. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin Cancer Res 2002; 8: 1075-1081 (Pubitemid 35177358)
32. Meng MV, Grossfeld GD, Williams GH, et al. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res 2001; 7: 2712-2718
33. Shreeram S, Sparks A, Lane DP, Blow JJ. Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene 2002; 21: 6624-6632 (Pubitemid 35177041)
34. Shreeram S, Blow JJ. The role of the replication licensing system in cell proliferation and cancer. Prog Cell Cycle Res 2003; 5: 287-293
35. Dixon RA, Ferreira D. Genistein. Phytochemistry 2002; 60: 205-211
36. Hikosaka A, Asamoto M, Hokaiwado N, et al. Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 2004; 25: 381-387
37. Tatsuta M, lishi H, Baba M, Yano H, Uehara H, Nakaizumi A. Attenuation by genistein of sodium-chloride-enhanced gastric carcinogenesis induced by W-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 1999; 80: 396-399
38. Wietrzyk J, Boratynski J, Grynkiewicz G, Ryczynski A, Radzikowski C, Opolski A. Antiangiogenic and artitumour effects in vivo of genistein applied alone or combined with cyclophosphamide. Anticancer Res 2001; 21: 3893-3896
39. Zhou JR, Mukherjee P, Gugger ET, Tanaka T, Blackburn GL, Clinton SK. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 1998; 58: 5231-5238 (Pubitemid 28521187)
40. Lei M. The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets 2005; 5: 365-380 (Pubitemid 41097760)
41. Lai EC Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002; 30: 363-364
42. Xie X, Lu J, Kulbokas EJ, et al. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 2005; 434: 338-345
43. Hernando E. microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transi Oncol 2007; 9: 155-160
44. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257-2261